Penny Stocks - Penny Stocks Picks - Hot Penny Stocks - Daily Penny Stock Picks - Top Penny Stock - Penny Stock Newsletter

WASHINGTON — President Obama said Monday that he was revamping American nuclear strategy to substantially narrow the conditions under which the United States would use nuclear weapons.

Read More:     http://nyti.ms/aAqYq4

According to the AAII weekly sentiment survey of retail US investors, 41.3% of respondents are bullish this week, that is a change of +8.9% from last week. And there are 31.2% bears, which is a slight decrease (-3.5%) from last week. Stepping back to gain a long term perspective, we find his survey to be in line with its long term average ratio of bull/bear. So it is not flagging an inordinate amount of optimism right now.

Read More:     http://bit.ly/bsuvv

“Our international network of more than 30,000 independent bloggers has run more than 3,000 click, banner, video, music and sponsored reviews for a wide range of clients over the past three years, and the business continues to grow rapidly,” noted Bloggerwave Director Ulrik Thomsen.

Read More:    http://bit.ly/d2Wgn1

Even after our people leave Goldman Sachs, they still identify with the firm and we want to foster that connection.  We have a rich history and tradition, and we invest in it.  Our alumni help us recruit.  They participate in volunteer activities.  They come back to speak to our people, and they do business with us.  Not only does this help validate our culture, it provides a real, tangible value that transcends any single generation.

Read More:  http://bit.ly/bDP0ZQ

I’m going to continue using 1163.25 as my Bull/Bear Line in Sand, which means the current near-term bias is Bullish. Tomorrow is also the last day of the month, and the market has a tendency to be bullish in the afternoon session.

Read More:     http://bit.ly/dmxETU

The playoff-bound Boston Celtics were rolling. The Kings, just two nights removed from losing to the team with the worst record in the NBA, looked ready to turn in another pitiful performance.

Read More:   http://bit.ly/cuNlAn

Top-flight biotech companies such as Genzyme  (GENZ, news, msgs)  don’t typically find themselves in the bargain bin. But since contamination problems began plaguing the company’s main manufacturing plant in Massachusetts in early 2009, investors have lost confidence. The shares, at $49.75, are off 29% since the problems surfaced.

Read More:    http://bit.ly/aUfOVd

The retreat in the inverse correlation between oil prices and the US dollar is set to continue into the quarter, with the US currency seen adding on to its gains despite robust energy prices ahead.

Read More:   http://bit.ly/6dR7D5